Frequent Detection of Pituitary-Derived PrPres in Human Prion Diseases

Hiroyuki Honda, Masaki Matsumoto, Masahiro Shijo, Hideomi Hamasaki, Shoko Sadashima, Satoshi O. Suzuki, Shinichi Aishima, Keita Kai, Keiichi I. Nakayama, Naokazu Sasagasako, Toru Iwaki

Research output: Contribution to journalArticle

Abstract

Human prion diseases including sporadic Creutzfeldt-Jakob disease (sCJD), inherited prion diseases, and acquired human prion diseases are lethal neurodegenerative diseases. One of the major sources of iatrogenic Creutzfeldt-Jakob disease was human growth hormone (hGH-iCJD) derived from contaminated cadaveric pituitaries. The incidence of hGH-iCJD has decreased since changing from growth hormone extracted from human cadaveric pituitaries to recombinant pituitary hormones. However, extensive analysis on the localization and detecting of abnormal prion protein in the pituitary gland are limited. In this study, we examined 9 autopsied brains and pituitary glands from 6 patients with prion disease (3 Gerstmann-Sträussler-Scheinker disease, 2 sCJD, and 1 dura mater graft-associated CJD) and 3 individuals with nonprion diseases. Western blot analysis of pituitary samples demonstrated unique glycoforms of normal cellular prion protein with molecular weights of 30-40 kDa, which was higher than the typical 25-35 kDa prion protein in brains. Proteomic analysis also revealed prion protein approximately the molecular weight of 40 kDa in pituitary samples. Moreover, proteinase K-resistant Prion protein was frequently detected in pituitary samples of the prion diseases. Immunohistochemistry for Prion protein revealed mosaic cellular distribution preferentially in growth hormone- or prolactin-producing cells.

Original languageEnglish
Pages (from-to)922-929
Number of pages8
JournalJournal of neuropathology and experimental neurology
Volume78
Issue number10
DOIs
Publication statusPublished - Oct 1 2019

Fingerprint

Prion Diseases
Human Growth Hormone
Pituitary Gland
Molecular Weight
Dura Mater
Endopeptidase K
Creutzfeldt-Jakob Syndrome
Pituitary Hormones
Brain
Neurodegenerative Diseases
Prolactin
Proteomics
Growth Hormone
Prion Proteins
Western Blotting
Immunohistochemistry
Transplants
Incidence

All Science Journal Classification (ASJC) codes

  • Pathology and Forensic Medicine
  • Neurology
  • Clinical Neurology
  • Cellular and Molecular Neuroscience

Cite this

Frequent Detection of Pituitary-Derived PrPres in Human Prion Diseases. / Honda, Hiroyuki; Matsumoto, Masaki; Shijo, Masahiro; Hamasaki, Hideomi; Sadashima, Shoko; Suzuki, Satoshi O.; Aishima, Shinichi; Kai, Keita; Nakayama, Keiichi I.; Sasagasako, Naokazu; Iwaki, Toru.

In: Journal of neuropathology and experimental neurology, Vol. 78, No. 10, 01.10.2019, p. 922-929.

Research output: Contribution to journalArticle

@article{38ca317a685f4665b95f3bbf8af6a2f7,
title = "Frequent Detection of Pituitary-Derived PrPres in Human Prion Diseases",
abstract = "Human prion diseases including sporadic Creutzfeldt-Jakob disease (sCJD), inherited prion diseases, and acquired human prion diseases are lethal neurodegenerative diseases. One of the major sources of iatrogenic Creutzfeldt-Jakob disease was human growth hormone (hGH-iCJD) derived from contaminated cadaveric pituitaries. The incidence of hGH-iCJD has decreased since changing from growth hormone extracted from human cadaveric pituitaries to recombinant pituitary hormones. However, extensive analysis on the localization and detecting of abnormal prion protein in the pituitary gland are limited. In this study, we examined 9 autopsied brains and pituitary glands from 6 patients with prion disease (3 Gerstmann-Str{\"a}ussler-Scheinker disease, 2 sCJD, and 1 dura mater graft-associated CJD) and 3 individuals with nonprion diseases. Western blot analysis of pituitary samples demonstrated unique glycoforms of normal cellular prion protein with molecular weights of 30-40 kDa, which was higher than the typical 25-35 kDa prion protein in brains. Proteomic analysis also revealed prion protein approximately the molecular weight of 40 kDa in pituitary samples. Moreover, proteinase K-resistant Prion protein was frequently detected in pituitary samples of the prion diseases. Immunohistochemistry for Prion protein revealed mosaic cellular distribution preferentially in growth hormone- or prolactin-producing cells.",
author = "Hiroyuki Honda and Masaki Matsumoto and Masahiro Shijo and Hideomi Hamasaki and Shoko Sadashima and Suzuki, {Satoshi O.} and Shinichi Aishima and Keita Kai and Nakayama, {Keiichi I.} and Naokazu Sasagasako and Toru Iwaki",
year = "2019",
month = "10",
day = "1",
doi = "10.1093/jnen/nlz075",
language = "English",
volume = "78",
pages = "922--929",
journal = "Journal of Neuropathology and Experimental Neurology",
issn = "0022-3069",
number = "10",

}

TY - JOUR

T1 - Frequent Detection of Pituitary-Derived PrPres in Human Prion Diseases

AU - Honda, Hiroyuki

AU - Matsumoto, Masaki

AU - Shijo, Masahiro

AU - Hamasaki, Hideomi

AU - Sadashima, Shoko

AU - Suzuki, Satoshi O.

AU - Aishima, Shinichi

AU - Kai, Keita

AU - Nakayama, Keiichi I.

AU - Sasagasako, Naokazu

AU - Iwaki, Toru

PY - 2019/10/1

Y1 - 2019/10/1

N2 - Human prion diseases including sporadic Creutzfeldt-Jakob disease (sCJD), inherited prion diseases, and acquired human prion diseases are lethal neurodegenerative diseases. One of the major sources of iatrogenic Creutzfeldt-Jakob disease was human growth hormone (hGH-iCJD) derived from contaminated cadaveric pituitaries. The incidence of hGH-iCJD has decreased since changing from growth hormone extracted from human cadaveric pituitaries to recombinant pituitary hormones. However, extensive analysis on the localization and detecting of abnormal prion protein in the pituitary gland are limited. In this study, we examined 9 autopsied brains and pituitary glands from 6 patients with prion disease (3 Gerstmann-Sträussler-Scheinker disease, 2 sCJD, and 1 dura mater graft-associated CJD) and 3 individuals with nonprion diseases. Western blot analysis of pituitary samples demonstrated unique glycoforms of normal cellular prion protein with molecular weights of 30-40 kDa, which was higher than the typical 25-35 kDa prion protein in brains. Proteomic analysis also revealed prion protein approximately the molecular weight of 40 kDa in pituitary samples. Moreover, proteinase K-resistant Prion protein was frequently detected in pituitary samples of the prion diseases. Immunohistochemistry for Prion protein revealed mosaic cellular distribution preferentially in growth hormone- or prolactin-producing cells.

AB - Human prion diseases including sporadic Creutzfeldt-Jakob disease (sCJD), inherited prion diseases, and acquired human prion diseases are lethal neurodegenerative diseases. One of the major sources of iatrogenic Creutzfeldt-Jakob disease was human growth hormone (hGH-iCJD) derived from contaminated cadaveric pituitaries. The incidence of hGH-iCJD has decreased since changing from growth hormone extracted from human cadaveric pituitaries to recombinant pituitary hormones. However, extensive analysis on the localization and detecting of abnormal prion protein in the pituitary gland are limited. In this study, we examined 9 autopsied brains and pituitary glands from 6 patients with prion disease (3 Gerstmann-Sträussler-Scheinker disease, 2 sCJD, and 1 dura mater graft-associated CJD) and 3 individuals with nonprion diseases. Western blot analysis of pituitary samples demonstrated unique glycoforms of normal cellular prion protein with molecular weights of 30-40 kDa, which was higher than the typical 25-35 kDa prion protein in brains. Proteomic analysis also revealed prion protein approximately the molecular weight of 40 kDa in pituitary samples. Moreover, proteinase K-resistant Prion protein was frequently detected in pituitary samples of the prion diseases. Immunohistochemistry for Prion protein revealed mosaic cellular distribution preferentially in growth hormone- or prolactin-producing cells.

UR - http://www.scopus.com/inward/record.url?scp=85072509116&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85072509116&partnerID=8YFLogxK

U2 - 10.1093/jnen/nlz075

DO - 10.1093/jnen/nlz075

M3 - Article

C2 - 31504701

AN - SCOPUS:85072509116

VL - 78

SP - 922

EP - 929

JO - Journal of Neuropathology and Experimental Neurology

JF - Journal of Neuropathology and Experimental Neurology

SN - 0022-3069

IS - 10

ER -